# Aprepitant in the Prevention of Cisplatin-induced Delayed Emesis

> **NCT00869310** · PHASE3 · TERMINATED · sponsor: **S. Maria Hospital, Terni** · enrollment: 303 (actual)

## Conditions studied

- Emesis

## Interventions

- **DRUG:** aprepitant + dexamethasone
- **DRUG:** metoclopramide + dexamethasone

## Key facts

- **NCT ID:** NCT00869310
- **Lead sponsor:** S. Maria Hospital, Terni
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 303 (ACTUAL)
- **Why stopped:** we terminated the study before enrolling 303/560 due to a slow accrual
- **Last updated:** 2014-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00869310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00869310, "Aprepitant in the Prevention of Cisplatin-induced Delayed Emesis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00869310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*